Cargando…
Rheb1 promotes tumor progression through mTORC1 in MLL-AF9-initiated murine acute myeloid leukemia
BACKGROUND: The constitutive hyper-activation of phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathways has frequently been associated with acute myeloid leukemia (AML). While many inhibitors targeting these pathways have been developed, t...
Autores principales: | Gao, Yanan, Gao, Juan, Li, Minghao, Zheng, Yawei, Wang, Yajie, Zhang, Hongyan, Wang, Weili, Chu, Yajing, Wang, Xiaomin, Xu, Mingjiang, Cheng, Tao, Ju, Zhenyu, Yuan, Weiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830070/ https://www.ncbi.nlm.nih.gov/pubmed/27071307 http://dx.doi.org/10.1186/s13045-016-0264-3 |
Ejemplares similares
-
Ubiquitination of Rheb governs growth factor-induced mTORC1 activation
por: Deng, Lu, et al.
Publicado: (2018) -
Coordination of Rheb lysosomal membrane interactions with mTORC1 activation
por: Angarola, Brittany, et al.
Publicado: (2020) -
Structural Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40
por: Yang, Haijuan, et al.
Publicado: (2017) -
Evaluation of the Binding Kinetics of RHEB with mTORC1 by In-Cell and In Vitro Assays
por: Shams, Raef, et al.
Publicado: (2021) -
Development of an RHEB-Targeting Peptide To Inhibit
mTORC1 Kinase Activity
por: Shams, Raef, et al.
Publicado: (2022)